Study: Abdominoplasty Patients Find Pain Relief with Xaracoll Implant
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.